Home > Insider Trading > Filing (0001104659-11-068718)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1076167	Adolor Corp	ADLR	Pharmaceutical Preparations (2834)	311429198

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
912183	Cubist Pharmaceuticals Inc	65 Hayden Avenue Lexington MA 02421		No	No	Yes	No
1533277	Frd Acquisition Corp	65 Hayden Avenue Lexington MA 02421		No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, $0.0001 Par Value	Acquisiton	2011-12-07	4,306,129	$4.25	40,397,039	No	4	P	Indirect	See footnote
Common Stock, $0.0001 Par Value	Acquisiton	2011-12-08	1,180,983	$4.25	41,578,022	No	4	P	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See footnote
No	4	P	Indirect	See footnote

Footnotes

The reported shares of Common Stock were acquired in a tender offer for $4.25 per share in cash, plus one nontransferable Contingent Payment Right entitling the holder to receive additional cash payments of up to $4.50 for each share tendered if certain regulatory approvals and/or commercialization milestones are met within agreed upon time periods, upon the terms and subject to the conditions set forth in the tender offer.
The reported shares are owned directly by FRD Acquisition Corporation, a wholly-owned subsidiary of Cubist Pharmaceuticals, Inc. Cubist Pharmaceuticals, Inc. is an indirect beneficial owner of the reported securities.